SEC Form 4 · accession 0001179110-17-014063

MEDICINES CO /DE · MDCO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Nov 9, 2017

Accepted (ET)

Nov 13, 2017 · 6:18 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001113481

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Nov 9, 2017	M	7,500	$18.30	A	123,133	D
Common Stock	Nov 9, 2017	M	7,500	$7.51	A	130,633	D
Common Stock	Nov 9, 2017	M	7,500	$8.28	A	138,133	D
Common Stock	Nov 9, 2017	M	13,259	$18.18	A	151,392	D
Common Stock	Nov 9, 2017	M	12,039	$21.14	A	163,431	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (right-to-buy)^F6,F1	$18.30	Nov 9, 2017	M	7,500	D	—	May 29, 2018	Common Stock	7,500	D
Stock Option (right-to-buy)^F6,F2	$7.51	Nov 9, 2017	M	7,500	D	—	May 28, 2019	Common Stock	7,500	D
Stock Option (right-to-buy)^F6,F3	$8.28	Nov 9, 2017	M	7,500	D	—	Jun 2, 2020	Common Stock	7,500	D
Stock Option (right-to-buy)^F6,F4	$18.18	Nov 9, 2017	M	13,259	D	—	May 26, 2021	Common Stock	13,259	D
Stock Option (right-to-buy)^F6,F5	$21.14	Nov 9, 2017	M	12,039	D	—	May 22, 2022	Common Stock	12,039	D

F1This option vested in twelve equal monthly installments beginning on June 29, 2008.
F2This option vested in twelve equal monthly installments beginning on June 28, 2009.
F3This option vested in twelve equal monthly installments beginning on July 2, 2010.
F4This option vested in one installment beginning on June 26, 2011.
F5This option vested in one installment beginning on June 22, 2012.
F6Not applicable